Xerostomia (Dry Mouth) Therapeutics Market Analysis By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2014 - 2025

Published: Sep, 2017 | Pages: 120 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global xerostomia therapeutics market is expected to reach USD 796.1 million by 2025, according to a new report by Grand View Research, Inc. Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth.

In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren's syndrome, diabetes, hypertension, and Parkinson's disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren's syndrome, an autoimmune disorder.

Growing initiatives for raising awareness about xerostomia and associated diseases are expected to drive growth. For instance, Sjogren Syndrome Foundation of America conducts awareness programs and supports patients suffering from the syndrome in the U.S. and Canada. In 2012, the foundation launched the "5-Year Breakthrough Goal" with an aim to reduce the time required to diagnose the condition to less than 2.5 years by 2017.

Furthermore, major players focus on acquiring emerging companies and conduct programs to raise awareness about dry mouth condition. For instance, Orajel, a brand of Church & Dwight Co., Inc. initiated a campaign with the help of iCrossing, a digital marketing agency to educate parents about the importance of oral care.

Further key findings from the report suggest:

• The global xerostomia (Dry Mouth) therapeutics market size was estimated at USD 602.3 million in 2016 and is expected to grow with CAGR of 3.2% from 2017 to 2025

• The OTC segment dominated the market due to factors such as ease in availability, affordability, and higher efficiency

• The dentifrices segment dominated the market in terms of revenue in 2016. Higher adoption of these products, accessibility, and affordability contribute to the dominance of the segment.

• North America held the largest share in 2016 owing to factors such as increasing prevalence of diseases resulting in dry mouth and growing initiatives for raising awareness about xerostomia

• The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increasing awareness of the disease and growing healthcare expenditure

• Some of the key players such as GlaxoSmithKline plc; Church & Dwight Co., Inc.; and Colgate-Palmolive Company dominated the global xerostomia therapeutics market in 2016

 Table of Contents

Chapter 1 Research Methodology & Scope
                 1.1 Information Procurement
                     1.1.1 Purchased database:
                     1.1.2 GVR's internal database
                 1.2 Research Methodology
                 1.3 Geographic Scope & Assumptions
                 1.4 Region-wise market calculation
                     1.4.1 Region-wise market: Base estimates
                     1.4.2 Global market: CAGR calculation
                 1.5 Region-based Segment Share Calculation
                 1.6 List of Secondary Sources
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 Xerostomia Therapeutics Market Variables, Trends& Scope
                 3.1 Market Segmentation& Scope
                     3.1.1 Market Driver Analysis
                         3.1.1.1 Growing geriatric population base
                         3.1.1.2 Growing prevalence of diseases such as Sjogren's Syndrome, HIV, diabetes, Alzheimer's disease, and others.
                         3.1.1.3 Increasing adoption of chemotherapy and radiotherapy in cancer treatment
                         3.1.1.4 Increasing use of prescription medicines
                         3.1.1.5 Easy availability and cost effectiveness of medicines
                     3.1.2 Market restraint analysis
                         3.1.2.1 Lack of awareness of xerostomia in developing and underdeveloped economies.
                         3.1.2.2 Nonavailability of effective treatment.
                 3.2 Penetration & GrowthPprospect Mapping
                 3.3 Xerostomia Therapeutics- SWOT Analysis, By Factor (political & legal, economic and technological)
                 3.4 Industry Analysis - Porter's
Chapter 4 Xerostomia Therapeutics Market: Type Estimates & Trend Analysis
                 4.1 Xerostomia Therapeutics market: Type Movement Analysis
                 4.2 OTC Products
                     4.2.1 OTC Products market, 2014 - 2025 (USD Million)
                 4.3 Prescription
                     4.3.1 Prescription products market, 2014 - 2025 (USD Million)
Chapter 5 Xerostomia Therapeutics Market: Product Estimates & Trend Analysis
                 5.1 Xerostomia Therapeutics market: Product Movement Analysis
                 5.2 Salivary Stimulants
                     5.2.1 Salivary stimulants market, 2014 - 2025 (USD Million)
                 5.3 Salivary Substitutes
                     5.3.1 Salivary substitutes market, 2014 - 2025 (USD Million)
                 5.4 Dentifrices
                     5.4.1 Dentifrices market, 2014 - 2025 (USD Million)
Chapter 6 Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis, by Application
                 6.1 Xerostomia Therapeutics market share, by region, 2015 & 2024
                 6.2 North America
                     6.2.1 North America Xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.2.2 U.S
                         6.2.2.1 U.S xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.2.3 Canada
                         6.2.3.1 Canada xerostomia therapeutics market, 2014 - 2025 (USD Million)
                 6.3 Europe
                     6.3.1 Europe Xerostomia Therapeutics market, 2014 - 2025 (USD Million)
                     6.3.2 UK
                         6.3.2.1 UK xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.3.3 Germany
                         6.3.3.1 Germany xerostomia therapeutics market, 2014 - 2025 (USD Million)
                 6.4 Asia Pacific
                     6.4.1 Asia Pacific xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.4.2 Japan
                         6.4.2.1 Japan xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.4.3 China
                         6.4.3.1 China xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.4.4 India
                         6.4.4.1 India xerostomia therapeutics market, 2014 - 2025 (USD Million)
                 6.5 Latin America
                     6.5.1 Latin America xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.5.2 Brazil
                         6.5.2.1 Brazil xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.5.3 Mexico
                         6.5.3.1 Mexico xerostomia therapeutics market, 2014 - 2025 (USD Million)
                 6.6 MEA
                     6.6.1 MEA xerostomia therapeutics market, 2014 - 2025 (USD Million)
                     6.6.2 South Africa
                         6.6.2.1 South Africa xerostomia therapeutics market, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                 7.1 Strategy Framework
                 7.2 Market Participation Categorization
                 7.3 Company Profiles
                     7.3.1 Acacia Pharma
                         7.3.1.1 Company overview
                         7.3.1.2 Financial performance
                         7.3.1.3 Product benchmarking
                         7.3.1.4 Strategic initiatives
                     7.3.2 Parnell Pharmaceuticals, Inc.
                         7.3.2.1 Company overview
                         7.3.2.2 Financial performance
                         7.3.2.3 Product benchmarking
                     7.3.3 Pfizer, Inc.
                         7.3.3.1 Company overview
                         7.3.3.2 Financial performance
                         7.3.3.3 Product benchmarking
                         7.3.3.4 Strategic initiatives
                     7.3.4 GlaxoSmithKline plc
                         7.3.4.1 Company overview
                         7.3.4.2 Financial overview
                         7.3.4.3 Product benchmarking
                     7.3.5 Church & Dwight Co., Inc.
                         7.3.5.1 Company overview
                         7.3.5.2 Financial overview
                         7.3.5.3 Product benchmarking
                         7.3.5.4 Strategic initiatives
                     7.3.6 Lupin
                         7.3.6.1 Company overview
                         7.3.6.2 Financial overview
                         7.3.6.3 Product benchmarking
                         7.3.6.4 Strategic initiatives
                     7.3.7 Sun Pharmaceutical Industries, Ltd.
                         7.3.7.1 Company overview
                         7.3.7.2 Financial overview
                         7.3.7.1 Product benchmarking
                     7.3.8 Hikma Pharmaceuticals PLC
                         7.3.8.1 Company overview
                         7.3.8.2 Financial overview
                         7.3.8.3 Product benchmarking
                         7.3.8.4 Strategic initiatives
                     7.3.9 Pendopharm
                         7.3.9.1 Company overview
                         7.3.9.2 Financial overview
                         7.3.9.3 Product benchmarking
                     7.3.10 OraCoat
                         7.3.10.1 Company overview
                         7.3.10.2 Financial overview
                         7.3.10.3 Product benchmarking

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 3 North America xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 4 U.S. xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 5 U.S xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 6 Canada xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 7 Canada xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 8 Europe xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 9 Europe xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 10 UK xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 11 UK xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 12 Germany xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 13 Germany xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 14 Asia Pacific Xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 15 Asia Pacific xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 16 Japan xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 17 Japan xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 18 China xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 19 China xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 20 India xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 21 India xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 22 Latin America xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 23 Latin America xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 25 Brazil xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 26 Brazil xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 27 Mexico xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 28 Mexico xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 29 MEA xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 30 MEA xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 31 South Africa xerostomia therapeutics market estimates and forecasts, by type, 2014 - 2025 (USD Million)
TABLE 32 South Africa xerostomia therapeutics market estimates and forecasts, by product, 2014 - 2025 (USD Million)
TABLE 33 List of Market Players